252 related articles for article (PubMed ID: 33481839)
1. Renal function in a cohort of HIV-infected patients initiating antiretroviral therapy in an outpatient setting in Ethiopia.
Fiseha T; Gebreweld A
PLoS One; 2021; 16(1):e0245500. PubMed ID: 33481839
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
3. Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy.
Zhao Y; Zhang M; Shi CX; Zhang Y; Cai W; Zhao Q; Li Y; Li H; Liu X; Chen L; Ma Y; Zhang F; Liu Z; Wu Z
PLoS One; 2015; 10(8):e0135462. PubMed ID: 26317657
[TBL] [Abstract][Full Text] [Related]
4. Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.
De Waal R; Cohen K; Fox MP; Stinson K; Maartens G; Boulle A; Igumbor EU; Davies MA
J Int AIDS Soc; 2017 Apr; 20(1):21317. PubMed ID: 28406595
[TBL] [Abstract][Full Text] [Related]
5. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
[TBL] [Abstract][Full Text] [Related]
6. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
[TBL] [Abstract][Full Text] [Related]
7. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
9. No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
Smitson CC; Tenna A; Tsegaye M; Alemu AS; Fekade D; Aseffa A; Blumberg HM; Kempker RR
PLoS One; 2014; 9(1):e85698. PubMed ID: 24465651
[TBL] [Abstract][Full Text] [Related]
10. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
Reid A; Stöhr W; Walker AS; Williams IG; Kityo C; Hughes P; Kambugu A; Gilks CF; Mugyenyi P; Munderi P; Hakim J; Gibb DM;
Clin Infect Dis; 2008 Apr; 46(8):1271-81. PubMed ID: 18444867
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of malnutrition and associated factors among adult patients on antiretroviral therapy follow-up care in Jimma Medical Center, Southwest Ethiopia.
Daka DW; Ergiba MS
PLoS One; 2020; 15(3):e0229883. PubMed ID: 32163485
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia.
Gebreweld A; Fiseha T; Girma N; Haileslasie H; Gebretsadik D
PLoS One; 2020; 15(9):e0239215. PubMed ID: 32931523
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
[TBL] [Abstract][Full Text] [Related]
14. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
Fiseha T; Ebrahim H; Ebrahim E; Gebreweld A
PLoS One; 2022; 17(3):e0265740. PubMed ID: 35324948
[TBL] [Abstract][Full Text] [Related]
16. Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study.
Lee KH; Lee JU; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
Yonsei Med J; 2017 Jul; 58(4):770-777. PubMed ID: 28540990
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
[TBL] [Abstract][Full Text] [Related]
18. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia.
Damtew B; Mengistie B; Alemayehu T
Pan Afr Med J; 2015; 22():138. PubMed ID: 26889319
[TBL] [Abstract][Full Text] [Related]
19. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
Tanuma J; Jiamsakul A; Makane A; Avihingsanon A; Ng OT; Kiertiburanakul S; Chaiwarith R; Kumarasamy N; Nguyen KV; Pham TT; Lee MP; Ditangco R; Merati TP; Choi JY; Wong WW; Kamarulzaman A; Yunihastuti E; Sim BL; Ratanasuwan W; Kantipong P; Zhang F; Mustafa M; Saphonn V; Pujari S; Sohn AH;
PLoS One; 2016; 11(8):e0161562. PubMed ID: 27560968
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]